Vivos Therapeutics (VVOS) Revenue (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Revenue of $5.1 million for Q1 2026, up 70.46% year-over-year from $3.0 million in Q1 2025, and up 34.44% quarter-over-quarter from $3.8 million in Q4 2025.
Vivos Therapeutics (VVOS) Revenue (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Revenue for 7 consecutive years, with $5.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 70.46% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $19.6 million (up 33.77% YoY), while the FY2025 annual figure was $17.4 million, up 16.05% from the prior year.
- Revenue grew to $5.1 million in Q1 2026 per VVOS's latest filing, from $3.8 million in the prior quarter.
- Across five years, Revenue topped out at $6.8 million in Q3 2025 and bottomed at $3.0 million in Q1 2025.
- Historically, Revenue has averaged $4.0 million across 5 years, with a median of $3.8 million in 2025.
- Annual changes were most pronounced in 2023 — Revenue dropped 22.26% — and 2025, when it surged 75.73%.
- Vivos Therapeutics' Revenue stood at $4.0 million in 2022, then retreated by 17.77% to $3.2 million in 2023, then rose by 13.85% to $3.7 million in 2024, then advanced by 3.41% to $3.8 million in 2025, then jumped by 34.44% to $5.1 million in 2026.
- Business Quant data shows VVOS's Revenue at $5.1 million in Q1 2026, $3.8 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 6.59 Bn |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 5.44 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 1.74 Bn |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 1.31 Bn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 5.30 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 9.61 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Vivos Therapeutics | 4.79 Mn | 2.99 Mn | 2.95 Mn | 5.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.14 Mn |
| Dec 31, 2025 | 3.82 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 4.05 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.86 Mn |
| Dec 31, 2022 | 3.95 Mn |
| Sep 30, 2022 | 4.25 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | 4.55 Mn |
| Jun 30, 2021 | 4.50 Mn |